Biologic treatment of psoriasis in oncologic patients.

: Biologic treatment for moderate-severe psoriasis should be considered in oncologic patients since it is not formally contraindicated and is safe. Moreover, the efficacy and safety profile of IL-23 and IL-17 inhibitors, may be advantageous for those patients.